Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats

Journal of Neurosurgery
F D VrionisV Cherington

Abstract

A promising strategy in the treatment of neoplastic meningitis involves the use of herpes simplex virus-thymidine kinase (HSV-tk)-modified cells. In these experiments the authors used cells expressing HSV-tk to treat meningeal carcinomatosis in the rat Walker 256 model. Intrathecal injection of 2 x 10(5) Walker cells resulted in a median survival time of 15 days. Up to 80% of animals implanted with HSV-tk-modified Walker cells (Walker-tk+) and treated with ganciclovir showed long-term survival (120 days or more), whereas the remaining animals died from tumor growth between 37 and 44 days after implantation. Tumor cells from an animal in which the treatment failed were cultured in vitro and were shown to be still sensitive to ganciclovir. However, continuous ganciclovir administration for 6 weeks rather than 2 weeks did not improve survival. Histopathological studies confirmed leptomeningeal infiltration in the untreated Walker or Walker-tk+ animals. Walker-tk+ cells were mixed with Walker cells in 1:1, 10:1, or 50:1 ratios, respectively, and implanted intrathecally; the animals were treated with ganciclovir. All groups of treated animals had long-term survivors, with 40% of the rats in the 10:1 and 50:1 groups demonstrating lon...Continue Reading

References

May 1, 1992·Journal of Neuro-oncology·H NakagawaT Hayakawa
Jul 1, 1992·Neuron·A L Halliday, C L Cepko
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S C Fields-BerryC L Cepko
Nov 1, 1990·Journal of Neuroscience Research·M P ShortR L Martuza
Feb 21, 1990·Journal of the National Cancer Institute·F L Moolten, J M Wells
Aug 1, 1986·Molecular and Cellular Biology·A D Miller, C Buttimore
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·D BarbaF H Gage
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M CarusoD Klatzmann
Jul 1, 1993·Journal of Neurosurgery·Y TakamiyaR L Martuza
Nov 1, 1993·Journal of Neurosurgery·D BarbaF H Gage

❮ Previous
Next ❯

Citations

Apr 12, 2007·Bulletin of Experimental Biology and Medicine·I I KhegaiL N Ivanova
May 16, 2014·Bulletin of Experimental Biology and Medicine·A V EfremovYu V Pakhomova
Sep 5, 2006·Critical Reviews in Oncology/hematology·Andrea Pace, Alessandra Fabi
Nov 26, 2008·Bulletin of Experimental Biology and Medicine·I I KhegayL N Ivanova

❮ Previous
Next ❯

Methods Mentioned

BETA
phosphotransferase
transfection

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.